Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
Q2M2H8
UPID:
MGAL_HUMAN
Alternative names:
Maltase-glucoamylase (alpha-glucosidase) pseudogene
Alternative UPACC:
Q2M2H8; A4D2I3; C9JNC2
Background:
Probable maltase-glucoamylase 2, also known as Maltase-glucoamylase (alpha-glucosidase) pseudogene, plays a crucial role in carbohydrate metabolism by breaking down complex sugars into glucose. This enzyme's activity is essential for the efficient digestion of starch, making it a vital component in the human digestive system.
Therapeutic significance:
Understanding the role of Probable maltase-glucoamylase 2 could open doors to potential therapeutic strategies. Its pivotal function in carbohydrate digestion suggests that modulation of its activity could offer new avenues for treating metabolic disorders and enhancing nutritional absorption.